<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-BMWC9X3R</identifier><date>2017</date><creator>Novak Šarotar, Brigita</creator><relation>documents/doc/B/URN_NBN_SI_doc-BMWC9X3R_001.pdf</relation><relation>documents/doc/B/URN_NBN_SI_doc-BMWC9X3R_001.txt</relation><format format_type="issue">1/2</format><format format_type="volume">7</format><format format_type="type">article</format><format format_type="extent">str. 48-53</format><identifier identifier_type="ISSN">2232-416X</identifier><identifier identifier_type="COBISSID">33374937</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-BMWC9X3R</identifier><language>eng</language><publisher publisher_location="Murska Sobota">PAZU</publisher><source>Anali PAZU</source><rights>BY-NC-ND</rights><subject language_type_id="slv">antipsihotična zdravila</subject><subject language_type_id="eng">antipsychotic drugs</subject><subject language_type_id="eng">schizophrenia</subject><subject language_type_id="slv">shizofrenija</subject><subject language_type_id="eng">treatment</subject><subject language_type_id="slv">zdravljenje</subject><title>Antipsihotična zdravila in podaljšanje QT intervala</title><title>Antipsychotic drugs and QT interval prolongation</title></Record>